Sientra (SIEN) Set to Announce Quarterly Earnings on Thursday
Sientra (SIEN) Set to Announce Quarterly Earnings on Thursday
Sientra (NASDAQ:SIEN – Get Rating) will be posting its quarterly earnings results after the market closes on Thursday, August 11th. Analysts expect Sientra to post earnings of ($0.23) per share for the quarter. Sientra has set its FY 2022 guidance at EPS.Parties interested in participating in the company's conference call can do so using this link.
西恩特拉(納斯達克：SIEN-GET評級)將在8月11日(星期四)股市收盤後公佈季度收益結果。分析師預計，西門子將公佈本季度每股收益為0.23美元。Sientra已經將其2022財年的指導定為EPS。有興趣參加該公司電話會議的各方可以使用以下鏈接進行操作。
Sientra (NASDAQ:SIEN – Get Rating) last announced its quarterly earnings data on Thursday, May 12th. The medical instruments supplier reported ($0.29) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.03). Sientra had a negative net margin of 71.61% and a negative return on equity of 498.54%. The firm had revenue of $21.40 million during the quarter, compared to analysts' expectations of $20.25 million. On average, analysts expect Sientra to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
西恩特拉(納斯達克：SIEN-GET評級)上一次公佈季度收益數據是在5月12日星期四。這家醫療器械供應商公佈了該季度每股收益(0.29美元)，低於分析師普遍預期的(0.26美元)和(0.03美元)。西門子的淨利潤率為負71.61%，淨資產回報率為負498.54%。該公司本季度營收為2,140萬美元，高於分析師預期的2,025萬美元。分析師平均預計，Sientra本財年每股收益為-1美元，下一財年為-1美元。
Sientra Trading Up 7.1 %
Sientra交易上漲7.1%
Shares of NASDAQ:SIEN opened at $1.06 on Thursday. Sientra has a 52 week low of $0.70 and a 52 week high of $7.95. The company's 50 day moving average is $0.92 and its two-hundred day moving average is $1.77. The company has a current ratio of 1.59, a quick ratio of 0.95 and a debt-to-equity ratio of 2.61. The company has a market cap of $66.40 million, a PE ratio of -1.07 and a beta of 1.94.
納斯達克：西安股價週四開盤報1.06美元。Sientra的52周低點為0.70美元，52周高點為7.95美元。該公司的50日移動均線切入位在0.92美元，200日移動均線切入位在1.77美元。該公司的流動比率為1.59，速動比率為0.95，債務權益比率為2.61。該公司市值為6,640萬美元，市盈率為-1.07，貝塔係數為1.94。
Institutional Trading of Sientra
Sientra的機構交易
Analyst Ratings Changes
分析師評級發生變化
SIEN has been the topic of a number of recent analyst reports. Lake Street Capital started coverage on shares of Sientra in a research report on Thursday, April 14th. They issued a "buy" rating and a $8.00 price objective on the stock. Maxim Group reaffirmed a "buy" rating and issued a $5.00 target price on shares of Sientra in a research report on Friday, May 13th. StockNews.com downgraded shares of Sientra from a "hold" rating to a "sell" rating in a research report on Tuesday, May 10th. Finally, Canaccord Genuity Group dropped their target price on shares of Sientra from $8.00 to $5.00 in a research report on Friday, May 13th. One analyst has rated the stock with a sell rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Sientra has a consensus rating of "Moderate Buy" and a consensus target price of $7.29.
Sien一直是最近許多分析師報告的主題。Lake Street Capital在4月14日星期四的一份研究報告中開始報道Sientra的股票。他們對該股的評級為“買入”，目標價為8.00美元。Maxim Group在5月13日(星期五)的一份研究報告中重申了對Sientra的“買入”評級，並對其股票發佈了5.00美元的目標價。在5月10日週二的一份研究報告中，StockNews.com將Sientra的股票評級從持有下調至賣出。最後，在5月13日星期五的一份研究報告中，Canaccel Genuity Group將Sientra的股票目標價從8.00美元下調至5.00美元。一名分析師對該股的評級為賣出，六名分析師對該股的評級為買入。根據MarketBeat.com的數據，Sientra的共識評級為“適度買入”，共識目標價為7.29美元。
About Sientra
關於Sientra
(Get Rating)
(獲取評級)
Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.
Sientra，Inc.是一家醫學美學公司，在美國和國際上開發和銷售醫學美學產品。該公司提供用於隆胸和乳房再造手術的硅膠乳房植入物；乳房組織擴張器；以及Sientra圓形、Sientra TearDrop、allX2、Dermaspan、SoftSpan和BIOCORNEUM品牌的疤痕處理產品。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on Sientra (SIEN)
- There Are Different Types of Stock To Invest In
- Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
- Is Starbucks Shooting For The Moon?
- PayPal Continues To Struggle As Competition Increases
- Two High-Yield Deep-Values You Shouldn't Ignore
- 免費獲取StockNews.com關於Sientra的研究報告(SIEN)
- 有不同類型的股票可供投資
- 是時候開發Molson Coors了，還是啤酒銷售會變得平淡？
- 星巴克是在向月球進軍嗎？
- PayPal繼續掙扎，競爭加劇
- 你不應該忽視的兩個高收益深度價值
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.
接受西恩特拉日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Sientra和相關公司的最新新聞和分析師評級的每日簡明摘要。
譯文內容由第三人軟體翻譯。